Sinotherapeutics Inc. A Cash Flow Reinvestment Rate
Sinotherapeutics Inc. A cash flow reinvestment rate. Sinotherapeutics Inc. A (688247) has a Cash Flow Reinvestment Rate of 2.10x as of December 2025, reinvesting CN¥200.10 Million (capex CN¥41.56 Million plus investments CN¥158.54 Million) from operating cash flow of CN¥95.33 Million. Explore Sinotherapeutics Inc. A cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sinotherapeutics Inc. A (2020–2025)
Cash flow reinvestment rate of Sinotherapeutics Inc. A from 2020 to 2025. Historical reinvestment intensity for Sinotherapeutics Inc. A across 6 annual periods. Explore 688247 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Sinotherapeutics Inc. A Cash Flow Reinvestment Rate by Year (2020–2025)
Sinotherapeutics Inc. A cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for Sinotherapeutics Inc. A. For the full cash flow conversion analysis, see Sinotherapeutics Inc. A operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.10x | CN¥200.10 Million | CN¥95.33 Million | CN¥41.56 Million | ▼ -43.5% |
| 2024 | 3.72x | CN¥483.84 Million | CN¥130.23 Million | CN¥94.93 Million | ▼ -55.2% |
| 2023 | 8.30x | CN¥107.57 Million | CN¥12.96 Million | CN¥38.96 Million | ▲ +61.3% |
| 2022 | 5.15x | CN¥376.64 Million | CN¥73.18 Million | CN¥176.34 Million | ▲ +835.0% |
| 2021 | 0.55x | CN¥80.24 Million | CN¥145.77 Million | CN¥16.01 Million | ▲ +80.0% |
| 2020 | 0.31x | CN¥64.23 Million | CN¥210.04 Million | CN¥38.34 Million | — |